Search results
Analysts revisit Humana stock price targets amid Medicare Advantage hit
TheStreet via Yahoo Finance· 4 days agoUnder the act, private health plans approved by Medicare became known as Medicare Advantage Plans....
Allwell Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 5 days agoStar ratings are determined by the Centers for Medicare & Medicaid Services (CMS). Allwell is a brand of Wellcare, which is owned by Centene. Wellcare by...
Supreme Court Puppet Master’s Consulting Firm Clients Exposed in Leak
Rolling Stone via Yahoo News· 4 hours agoLeonard Leo’s consulting firm has worked for Eli Lilly, the Koch network, and a dark-money group...
About 3.6 million Medicare beneficiaries could be eligible for Wegovy coverage, study shows
WSAU Wausau· 5 days ago(Reuters) - About 3.6 million overweight or obese patients with heart conditions insured under the...
5 Medicare rules to know before returning to work in retirement
Bankrate via Yahoo Finance· 7 days agoLet’s say you dropped your Part D coverage. If you fail to enroll in Medicare Part D — or a Medicare...
Wave of Amicus Briefs Back Drug Price Plan at Trial Court Stage
Bloomberg Law· 3 days agoThe Biden administration’s efforts to fend off legal challenges from the pharmaceutical industry battling Medicare drug price negotiations has drawn reinforcements ...
Wegovy could soon treat millions of Medicare patients
Quartz· 5 days agoMillions of Americans could now be eligible for Medicare to cover their prescriptions of the popular...
FDA approval of Wegovy could give millions on Medicare access to weight-loss drug
PhillyVoice.com· 5 days agoWith this new approval, and the drug's possible dual use, millions of people on Medicare may be able...
New rules mean 3.6 million Americans could get Wegovy via Medicare, costing billions
Medical Xpress· 5 days agoThe FDA's ruling potentially allows Wegovy prescription coverage for more than a quarter of 13.7...
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 6 hours agoBelbuca prescriptions grew 3.2% in the previous quarter and a similar trend is likely to have driven...